Felix Q.
Senior Director of Business Development @ Mytos | MS Biology -- Helping Scale and Automate Regenerative Cell Therapies to Improve Patient Access
- Role
- Senior Director of Business Development at Mytos
- Location
- Philadelphia, PA, US
- LinkedIn followers
- 500 followers
About Felix Q.
Felix Quagliarello is a seasoned business development professional with a passion for advancing patient care through cell and gene therapies (CGT), where the convergence of biology and automation offers transformative potential. As Senior Director of Business Development, Felix specializes in forging manufacturing partnerships that embed next-generation automation into a vertically integrated CDMO model tailored specifically for CGT. His approach focuses on reducing manufacturing costs, scaling production efficiently, minimizing batch failures, and accelerating clinical development timelines. Felix’s expertise extends across integrated technology platforms, including the Mytos iDEM, Cellares Cell Shuttle, and the Minaris AT TESSA platform.Felix has successfully brokered clinical and commercial manufacturing partnerships by leveraging both his scientific foundation and business development acumen. He holds a Master’s degree in Cell, Molecular, and Developmental Biology and brings 10-years of bench research experience, most recently at UPenn\'s Institute for Immunology under E. John Wherry; which informs his ability to bridge complex scientific requirements with scalable, automation-enabled solutions. His work champions an integrated CDMO approach, aligning innovative technologies with the operational and regulatory challenges of advanced therapy manufacturing.His focus spans regenerative cell therapies, cellular immunotherapies, gene therapies, and viral vectors. Felix is known for being a collaborative scientific partner, streamlining the transition from discovery to GMP manufacturing by tailoring solutions to each client’s unique needs—always with an eye toward scalability and therapeutic impact.In his previous role as Cell and Gene Therapy Specialist at Cytiva and STEMCELL Technologies, Felix supported programs from translational preclinical development through to commercial-scale manufacturing. His work included autologous and allogeneic CAR-T and stem cell-based workflows, bone marrow transplant and cord blood banking programs, and point-of-care regenerative medicine initiatives. He offered hands-on guidance on tissue and blood product processing, large-scale expansion, media and harvest optimization, and cryopreservation—helping clients implement efficient, GMP-compliant solutions.
Experience
Senior Director of Business Development
May 2025 — Present · Philadelphia, PA, US
Mytos Bio is a biotechnology startup focused on revolutionizing the manufacturing of cells for regenerative medicine. Our core innovation lies in the automation of cell culture and processing, specifically for induced pluripotent stem cells (iPSCs) and other progenitors, through our automated culture platform, the iDEM.🧬 Core Mission - To automate and scale the production of human cells, enabling more efficient, reproducible, and cost-effective manufacturing for cell-based regenerative medicines. What We Offer - the iDEM platform and Manufacturing-as-a-service through our vertically integrated CDMO (Contract Development and Manufacturing Organization): Mytos not only provides equipment but also acts as a partner in cell therapy manufacturing, offering end-to-end services.🤝 Value Proposition - Enables biotech companies and therapeutic developers to increase scale maintaining quality and reproducibility and decrease manufacturing costs.🤖 iDEM Capabilities - Automated bioprocessing, media exchange, passaging, and monitoring Integrating real-time culture visualization and analytics. or pluripotent stem cell expansion and differentiation. Reduced manual labor, contamination risk, increases process robustness and maintains quality and reproducibility. Target Applications - Regenerative cell therapy R&D, PD, clinical-grade and commercial-scale manufacturing of PSCs and derivative cell types through our vertically integrated CDMO providing seamless scale and significantly decreased manufacturing costs.
Education
Penn State University
Bachelor of Science (B.S.), Life Science
2005 — 2010
Villanova University
Master's degree, Biology, Immunology Focus
2021
Find verified contacts for anyone on LinkedIn
Unifers gives sales teams verified emails and direct dials, enriched profiles, and outreach that lands in the inbox.
Free plan included · No credit card required
This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.